| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Neoplasms | 43 | 2023 | 1424 | 3.070 |
Why?
|
| Leiomyoma | 27 | 2023 | 644 | 2.250 |
Why?
|
| Leiomyosarcoma | 16 | 2023 | 426 | 1.650 |
Why?
|
| Adenosarcoma | 3 | 2017 | 36 | 1.120 |
Why?
|
| Smooth Muscle Tumor | 5 | 2023 | 65 | 0.850 |
Why?
|
| Translocation, Genetic | 16 | 2023 | 1392 | 0.830 |
Why?
|
| Leiomyomatosis | 6 | 2022 | 69 | 0.790 |
Why?
|
| Endometrial Neoplasms | 9 | 2023 | 1380 | 0.710 |
Why?
|
| Chromosome Aberrations | 11 | 2017 | 1776 | 0.690 |
Why?
|
| Chromosomes, Human, Pair 8 | 4 | 2017 | 451 | 0.680 |
Why?
|
| Neurotransmitter Agents | 2 | 2021 | 661 | 0.620 |
Why?
|
| Placenta | 8 | 2024 | 1725 | 0.600 |
Why?
|
| HMGA2 Protein | 7 | 2012 | 101 | 0.570 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2017 | 55 | 0.540 |
Why?
|
| Nerve Tissue Proteins | 6 | 2021 | 4400 | 0.530 |
Why?
|
| Neoplasm Seeding | 2 | 2013 | 85 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2004 | 432 | 0.500 |
Why?
|
| Choriocarcinoma | 3 | 2017 | 121 | 0.460 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2013 | 46 | 0.420 |
Why?
|
| Endometrium | 9 | 2023 | 406 | 0.420 |
Why?
|
| Hydatidiform Mole | 3 | 2020 | 255 | 0.410 |
Why?
|
| Uterine Cervical Dysplasia | 4 | 2018 | 391 | 0.400 |
Why?
|
| Peritoneum | 1 | 2012 | 227 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2004 | 275 | 0.370 |
Why?
|
| Uterine Cervical Neoplasms | 8 | 2018 | 2039 | 0.360 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 921 | 0.350 |
Why?
|
| Uterus | 8 | 2024 | 661 | 0.350 |
Why?
|
| Placenta Diseases | 2 | 2023 | 199 | 0.340 |
Why?
|
| Myometrium | 6 | 2012 | 174 | 0.340 |
Why?
|
| In Situ Hybridization, Fluorescence | 19 | 2018 | 2510 | 0.330 |
Why?
|
| Stromal Cells | 3 | 2015 | 1334 | 0.320 |
Why?
|
| Fallopian Tubes | 1 | 2010 | 179 | 0.320 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 116 | 0.310 |
Why?
|
| Pelvic Neoplasms | 2 | 2022 | 249 | 0.310 |
Why?
|
| SNARE Proteins | 3 | 2017 | 80 | 0.310 |
Why?
|
| DNA Copy Number Variations | 3 | 2023 | 2045 | 0.300 |
Why?
|
| Synaptic Vesicles | 2 | 2021 | 187 | 0.290 |
Why?
|
| Kallmann Syndrome | 3 | 2023 | 142 | 0.290 |
Why?
|
| Immunohistochemistry | 19 | 2022 | 11061 | 0.280 |
Why?
|
| Chromosome Breakage | 7 | 2012 | 159 | 0.260 |
Why?
|
| Karyotyping | 11 | 2018 | 1176 | 0.260 |
Why?
|
| Hysterectomy | 8 | 2024 | 863 | 0.250 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 2184 | 0.240 |
Why?
|
| Cell Membrane | 4 | 2021 | 3641 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 18075 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2007 | 418 | 0.220 |
Why?
|
| Female | 91 | 2024 | 396520 | 0.220 |
Why?
|
| Loss of Heterozygosity | 3 | 2010 | 663 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 3 | 2013 | 706 | 0.220 |
Why?
|
| Trophoblasts | 3 | 2023 | 223 | 0.210 |
Why?
|
| Acetyltransferases | 1 | 2004 | 230 | 0.210 |
Why?
|
| Neurons | 3 | 2021 | 9515 | 0.210 |
Why?
|
| Agrin | 1 | 2023 | 75 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2008 | 853 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 1609 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2017 | 2948 | 0.200 |
Why?
|
| Papillomaviridae | 4 | 2003 | 1139 | 0.200 |
Why?
|
| Craniofacial Abnormalities | 3 | 2012 | 320 | 0.200 |
Why?
|
| Endometrial Hyperplasia | 1 | 2023 | 102 | 0.200 |
Why?
|
| Receptors, Cholinergic | 1 | 2023 | 243 | 0.200 |
Why?
|
| Placenta Previa | 1 | 2024 | 125 | 0.200 |
Why?
|
| Cyclin E | 2 | 2001 | 155 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2018 | 705 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2007 | 322 | 0.190 |
Why?
|
| Computational Biology | 2 | 2013 | 3564 | 0.190 |
Why?
|
| Papillomavirus Infections | 4 | 2018 | 1639 | 0.190 |
Why?
|
| Gene Expression Profiling | 7 | 2019 | 9525 | 0.190 |
Why?
|
| Ovarian Neoplasms | 5 | 2021 | 4904 | 0.190 |
Why?
|
| Chromosome Deletion | 5 | 2012 | 1384 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 92 | 0.180 |
Why?
|
| Scoliosis | 1 | 2008 | 793 | 0.180 |
Why?
|
| Myxoma | 1 | 2001 | 114 | 0.180 |
Why?
|
| Mediator Complex | 2 | 2018 | 106 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2019 | 2839 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2002 | 209 | 0.170 |
Why?
|
| Syntaxin 1 | 1 | 2020 | 29 | 0.170 |
Why?
|
| Phosphoproteins | 4 | 2002 | 2448 | 0.170 |
Why?
|
| Vaginal Smears | 1 | 2003 | 505 | 0.170 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2001 | 92 | 0.170 |
Why?
|
| Humans | 107 | 2024 | 766766 | 0.170 |
Why?
|
| Placenta Accreta | 1 | 2024 | 242 | 0.170 |
Why?
|
| Vulvar Neoplasms | 2 | 2003 | 266 | 0.170 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2001 | 238 | 0.170 |
Why?
|
| High Mobility Group Proteins | 4 | 2002 | 179 | 0.170 |
Why?
|
| Trans-Activators | 4 | 2002 | 2855 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2009 | 8621 | 0.160 |
Why?
|
| Adenomyoma | 1 | 2018 | 8 | 0.160 |
Why?
|
| Candida albicans | 1 | 2022 | 377 | 0.160 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2019 | 72 | 0.160 |
Why?
|
| Ki-67 Antigen | 4 | 2003 | 630 | 0.160 |
Why?
|
| Teratoma | 1 | 2021 | 405 | 0.160 |
Why?
|
| Serine Proteases | 1 | 2018 | 44 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 587 | 0.150 |
Why?
|
| Intracellular Membranes | 1 | 2019 | 386 | 0.150 |
Why?
|
| Adult | 43 | 2023 | 223307 | 0.150 |
Why?
|
| Pregnancy | 17 | 2024 | 30237 | 0.150 |
Why?
|
| Polyps | 2 | 2015 | 200 | 0.150 |
Why?
|
| Carcinoma | 3 | 2019 | 2324 | 0.150 |
Why?
|
| Stillbirth | 1 | 2021 | 381 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 3796 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2013 | 11651 | 0.150 |
Why?
|
| Munc18 Proteins | 1 | 2017 | 19 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2009 | 310 | 0.140 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2010 | 329 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 530 | 0.140 |
Why?
|
| R-SNARE Proteins | 1 | 2017 | 73 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1491 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1405 | 0.140 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2018 | 211 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12806 | 0.140 |
Why?
|
| Lanthanoid Series Elements | 1 | 2016 | 17 | 0.140 |
Why?
|
| Papillomavirus Vaccines | 1 | 2003 | 497 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 502 | 0.140 |
Why?
|
| Fibrosarcoma | 1 | 2018 | 313 | 0.130 |
Why?
|
| Abnormalities, Multiple | 4 | 2007 | 1424 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2008 | 313 | 0.130 |
Why?
|
| Liposarcoma | 1 | 2019 | 288 | 0.130 |
Why?
|
| DNA-Binding Proteins | 6 | 2009 | 9611 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 501 | 0.130 |
Why?
|
| Gene Fusion | 1 | 2018 | 356 | 0.130 |
Why?
|
| Vascular Neoplasms | 2 | 2016 | 167 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2010 | 480 | 0.130 |
Why?
|
| Membrane Fusion | 1 | 2017 | 265 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1494 | 0.120 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2015 | 89 | 0.120 |
Why?
|
| Mutation | 8 | 2021 | 30213 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2007 | 640 | 0.120 |
Why?
|
| Endometriosis | 4 | 2004 | 868 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2023 | 7868 | 0.120 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 163 | 0.120 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2015 | 68 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 2 | 2014 | 534 | 0.110 |
Why?
|
| Receptors, Estrogen | 3 | 2023 | 2251 | 0.110 |
Why?
|
| Chromosome Mapping | 8 | 2008 | 4619 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1256 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 14 | 4 | 2003 | 286 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1161 | 0.110 |
Why?
|
| Immunophenotyping | 4 | 2010 | 1867 | 0.110 |
Why?
|
| Germ-Line Mutation | 2 | 2013 | 1885 | 0.110 |
Why?
|
| Chromosome Banding | 2 | 2004 | 261 | 0.110 |
Why?
|
| Rats | 6 | 2020 | 23717 | 0.110 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2014 | 78 | 0.100 |
Why?
|
| p21-Activated Kinases | 1 | 2013 | 127 | 0.100 |
Why?
|
| Adenoma | 1 | 2023 | 2155 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.100 |
Why?
|
| Middle Aged | 30 | 2022 | 223257 | 0.100 |
Why?
|
| Precancerous Conditions | 1 | 1998 | 980 | 0.100 |
Why?
|
| Necrosis | 3 | 2022 | 1616 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2885 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2013 | 390 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2011 | 113 | 0.090 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 216 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 412 | 0.090 |
Why?
|
| Genomics | 2 | 2019 | 5923 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 15416 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2010 | 3601 | 0.090 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 218 | 0.090 |
Why?
|
| Connexin 43 | 1 | 2011 | 202 | 0.090 |
Why?
|
| Antibodies | 2 | 2018 | 2421 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2018 | 9404 | 0.090 |
Why?
|
| Genes, BRCA2 | 1 | 2013 | 591 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2023 | 474 | 0.090 |
Why?
|
| Chickens | 1 | 2012 | 842 | 0.090 |
Why?
|
| PAX2 Transcription Factor | 1 | 2010 | 86 | 0.090 |
Why?
|
| Lipoma | 2 | 2004 | 294 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1110 | 0.090 |
Why?
|
| Gap Junctions | 1 | 2011 | 230 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 3681 | 0.090 |
Why?
|
| Genes, BRCA1 | 1 | 2013 | 753 | 0.080 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 498 | 0.080 |
Why?
|
| Tumor Virus Infections | 3 | 2003 | 438 | 0.080 |
Why?
|
| ras Proteins | 2 | 2024 | 1055 | 0.080 |
Why?
|
| Animals | 22 | 2024 | 168930 | 0.080 |
Why?
|
| Mice | 14 | 2024 | 81889 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18330 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2001 | 193 | 0.080 |
Why?
|
| Prognosis | 7 | 2022 | 29948 | 0.080 |
Why?
|
| Gene Rearrangement | 3 | 2007 | 1142 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1999 | 370 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 735 | 0.080 |
Why?
|
| Hirsutism | 1 | 2008 | 66 | 0.080 |
Why?
|
| Cytogenetic Analysis | 4 | 2016 | 270 | 0.070 |
Why?
|
| Diagnosis, Differential | 7 | 2017 | 12985 | 0.070 |
Why?
|
| DNA Mutational Analysis | 4 | 2010 | 4114 | 0.070 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 83 | 0.070 |
Why?
|
| DNA Primers | 3 | 2008 | 2826 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 5690 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 712 | 0.070 |
Why?
|
| Uterine Hemorrhage | 3 | 2016 | 235 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 3186 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2014 | 1610 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2012 | 2717 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2010 | 711 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1621 | 0.070 |
Why?
|
| Mass Screening | 1 | 2003 | 5454 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 597 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 47 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 49 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 128 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 18984 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2004 | 2801 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
| Aged | 17 | 2019 | 171343 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 122 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.070 |
Why?
|
| Mosaicism | 2 | 2009 | 480 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 319 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2005 | 258 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 59550 | 0.060 |
Why?
|
| Infarction | 2 | 2023 | 247 | 0.060 |
Why?
|
| Decidua | 1 | 2006 | 80 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4282 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 163 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 1999 | 784 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 13640 | 0.060 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 260 | 0.060 |
Why?
|
| Germ Cells | 2 | 2018 | 645 | 0.060 |
Why?
|
| Mitotic Index | 2 | 2016 | 160 | 0.060 |
Why?
|
| Congenital Abnormalities | 2 | 2008 | 703 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 243 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 837 | 0.060 |
Why?
|
| DNA, Neoplasm | 3 | 2002 | 1741 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 737 | 0.060 |
Why?
|
| Fibronectins | 1 | 1988 | 722 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1612 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1751 | 0.060 |
Why?
|
| Genes, Neoplasm | 2 | 2004 | 369 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2002 | 1057 | 0.060 |
Why?
|
| Biopsy | 4 | 2019 | 6779 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 420 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3792 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2020 | 2603 | 0.060 |
Why?
|
| Cell Line | 5 | 2011 | 15563 | 0.060 |
Why?
|
| Keratin-14 | 2 | 2001 | 57 | 0.060 |
Why?
|
| Urogenital Abnormalities | 1 | 2007 | 255 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2007 | 1418 | 0.060 |
Why?
|
| Autistic Disorder | 3 | 2012 | 1238 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4049 | 0.060 |
Why?
|
| raf Kinases | 1 | 2024 | 117 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2007 | 622 | 0.060 |
Why?
|
| Carcinoma, Adenosquamous | 2 | 2001 | 66 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5861 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2007 | 305 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2023 | 1117 | 0.050 |
Why?
|
| Fetal Growth Retardation | 2 | 2006 | 591 | 0.050 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 433 | 0.050 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2023 | 118 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14652 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Fumarate Hydratase | 1 | 2022 | 55 | 0.050 |
Why?
|
| Urogenital System | 1 | 2002 | 88 | 0.050 |
Why?
|
| Keratins | 2 | 2001 | 499 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 332 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 191 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 950 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2019 | 6850 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2001 | 591 | 0.050 |
Why?
|
| Genome, Human | 2 | 2008 | 4443 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 3609 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 635 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 747 | 0.050 |
Why?
|
| Adolescent | 5 | 2023 | 88904 | 0.050 |
Why?
|
| Desmin | 1 | 2001 | 99 | 0.050 |
Why?
|
| Base Sequence | 3 | 2008 | 12415 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2021 | 318 | 0.040 |
Why?
|
| Adenocarcinoma | 4 | 2003 | 6359 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2023 | 399 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 4780 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 11218 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2008 | 2201 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2003 | 1103 | 0.040 |
Why?
|
| Gynecology | 2 | 2019 | 534 | 0.040 |
Why?
|
| Observer Variation | 2 | 2019 | 2614 | 0.040 |
Why?
|
| Neprilysin | 1 | 2003 | 487 | 0.040 |
Why?
|
| DNA Damage | 1 | 2010 | 2467 | 0.040 |
Why?
|
| Cleft Lip | 1 | 2005 | 512 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2004 | 588 | 0.040 |
Why?
|
| Phenotype | 4 | 2018 | 16724 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2020 | 3947 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2000 | 144 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2005 | 596 | 0.040 |
Why?
|
| Adnexa Uteri | 1 | 2019 | 40 | 0.040 |
Why?
|
| Retrospective Studies | 10 | 2024 | 81635 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2008 | 1519 | 0.040 |
Why?
|
| Fetal Death | 1 | 2021 | 434 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14471 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2016 | 1900 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 904 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 423 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2016 | 2870 | 0.040 |
Why?
|
| DNA, Viral | 3 | 2001 | 2201 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2022 | 41710 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2003 | 12791 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 891 | 0.040 |
Why?
|
| Clone Cells | 1 | 2002 | 1670 | 0.040 |
Why?
|
| Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
| Ploidies | 1 | 2019 | 287 | 0.040 |
Why?
|
| Online Systems | 1 | 2019 | 181 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2023 | 1159 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 59939 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2003 | 1186 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7609 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 1697 | 0.040 |
Why?
|
| Cysteine | 1 | 2022 | 896 | 0.040 |
Why?
|
| Cicatrix | 1 | 2024 | 798 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 769 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 69 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.040 |
Why?
|
| Calorimetry | 1 | 2017 | 132 | 0.040 |
Why?
|
| RNA | 2 | 2004 | 2715 | 0.040 |
Why?
|
| Mucins | 1 | 2000 | 569 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2023 | 24295 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2083 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 931 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2001 | 575 | 0.030 |
Why?
|
| Self Disclosure | 1 | 2018 | 248 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11872 | 0.030 |
Why?
|
| Telomere | 1 | 2003 | 943 | 0.030 |
Why?
|
| Syndrome | 3 | 2007 | 3271 | 0.030 |
Why?
|
| Sarcoma | 1 | 2007 | 1802 | 0.030 |
Why?
|
| Epithelium | 1 | 2001 | 1606 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11094 | 0.030 |
Why?
|
| Neoplasms | 2 | 2024 | 22350 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2002 | 3691 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 3607 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.030 |
Why?
|
| Atrophy | 1 | 2001 | 1631 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 1175 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2016 | 390 | 0.030 |
Why?
|
| Fetus | 2 | 2000 | 1878 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2001 | 784 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 1027 | 0.030 |
Why?
|
| Aging | 2 | 2012 | 8731 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2024 | 1418 | 0.030 |
Why?
|
| Point Mutation | 1 | 2020 | 1591 | 0.030 |
Why?
|
| Freeze Fracturing | 2 | 2011 | 68 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2023 | 23619 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Human Genome Project | 2 | 2008 | 202 | 0.030 |
Why?
|
| Cerebellum | 1 | 2021 | 1520 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5022 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1354 | 0.030 |
Why?
|
| Seizures | 1 | 2007 | 2996 | 0.030 |
Why?
|
| X Chromosome | 1 | 1997 | 819 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 17608 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2007 | 722 | 0.030 |
Why?
|
| Oviducts | 1 | 2012 | 11 | 0.030 |
Why?
|
| Decision Trees | 1 | 1995 | 508 | 0.030 |
Why?
|
| Poultry Diseases | 1 | 2012 | 24 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 3757 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17088 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2926 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 721 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 6066 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2014 | 694 | 0.020 |
Why?
|
| Filipin | 1 | 2011 | 14 | 0.020 |
Why?
|
| Premenopause | 3 | 2002 | 1039 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8307 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 1892 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2020 | 2867 | 0.020 |
Why?
|
| New England | 1 | 2015 | 1059 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 2413 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2019 | 65273 | 0.020 |
Why?
|
| Time Factors | 4 | 2016 | 40149 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2023 | 3464 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2013 | 612 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2000 | 2572 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 960 | 0.020 |
Why?
|
| Quinazolinones | 1 | 2012 | 219 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4570 | 0.020 |
Why?
|
| Male | 13 | 2019 | 364142 | 0.020 |
Why?
|
| Mitosis | 1 | 2016 | 1176 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1997 | 1089 | 0.020 |
Why?
|
| Trisomy | 1 | 1992 | 260 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 135 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8735 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2011 | 241 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2012 | 339 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3716 | 0.020 |
Why?
|
| Heterozygote | 1 | 1997 | 2795 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 334 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2023 | 4924 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1992 | 534 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26389 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 13411 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 6104 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 939 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 22352 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1988 | 37 | 0.020 |
Why?
|
| Hippocampus | 1 | 2021 | 3776 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 542 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 1688 | 0.020 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pathology, Clinical | 1 | 2012 | 374 | 0.020 |
Why?
|
| Risk Factors | 4 | 2015 | 74881 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4891 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6512 | 0.020 |
Why?
|
| Prevalence | 2 | 2018 | 15835 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1677 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3666 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7585 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2008 | 2590 | 0.020 |
Why?
|
| Menstrual Cycle | 2 | 2002 | 539 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2003 | 1989 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5143 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 2 | 2003 | 136 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2902 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1331 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 1075 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1987 | 198 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2001 | 12150 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1206 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4249 | 0.020 |
Why?
|
| Disulfides | 1 | 1988 | 462 | 0.020 |
Why?
|
| Factor VIII | 1 | 1988 | 349 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3957 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1993 | 790 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2168 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2007 | 774 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20144 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 19 | 0.020 |
Why?
|
| Child | 4 | 2024 | 80668 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2007 | 4142 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 1987 | 387 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 243 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 742 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9346 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 9101 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2007 | 4522 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 364 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2014 | 5386 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2023 | 54871 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1993 | 1255 | 0.010 |
Why?
|
| Piperidines | 1 | 2012 | 1663 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1992 | 1772 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
| Face | 2 | 2004 | 1029 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2011 | 2605 | 0.010 |
Why?
|
| Euchromatin | 1 | 2003 | 54 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2003 | 104 | 0.010 |
Why?
|
| Reoperation | 1 | 2013 | 4325 | 0.010 |
Why?
|
| Maternal Age | 1 | 2006 | 804 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1997 | 4427 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 251 | 0.010 |
Why?
|
| Clitoris | 1 | 2002 | 35 | 0.010 |
Why?
|
| Cholesterol | 1 | 2011 | 2903 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2006 | 573 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 162 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6507 | 0.010 |
Why?
|
| Gene Duplication | 1 | 2003 | 315 | 0.010 |
Why?
|
| Hysteroscopy | 1 | 2002 | 62 | 0.010 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 115 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7431 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 96 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1675 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2003 | 292 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 1325 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2003 | 326 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 125 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 415 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 195 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1993 | 2184 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9244 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 3035 | 0.010 |
Why?
|
| Carcinoma, Large Cell | 1 | 2001 | 114 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 281 | 0.010 |
Why?
|
| Collagen | 1 | 1988 | 2635 | 0.010 |
Why?
|
| Gonads | 1 | 2000 | 109 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 2000 | 69 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2003 | 36567 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2004 | 634 | 0.010 |
Why?
|
| Metaplasia | 1 | 2001 | 326 | 0.010 |
Why?
|
| Anal Canal | 1 | 2002 | 375 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4539 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 386 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10445 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1811 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2039 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1998 | 421 | 0.010 |
Why?
|
| Analgesia | 1 | 2003 | 461 | 0.010 |
Why?
|
| Parity | 1 | 2002 | 931 | 0.010 |
Why?
|
| CpG Islands | 1 | 2003 | 1208 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2003 | 606 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 171 | 0.010 |
Why?
|
| Birth Weight | 1 | 2006 | 2123 | 0.010 |
Why?
|
| DNA Probes | 1 | 1998 | 541 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 13036 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1550 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22248 | 0.010 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2000 | 385 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 27159 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1505 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1750 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 1137 | 0.010 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2001 | 343 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3617 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 42577 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2677 | 0.010 |
Why?
|
| Protein Binding | 1 | 1988 | 9320 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 4166 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2177 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1756 | 0.010 |
Why?
|
| Kidney | 2 | 2007 | 7074 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2001 | 791 | 0.010 |
Why?
|
| Menstruation | 1 | 1997 | 310 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1966 | 0.010 |
Why?
|
| Oocytes | 1 | 2000 | 1168 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 14072 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4168 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3487 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3609 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2270 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6976 | 0.010 |
Why?
|
| United States | 1 | 2021 | 72951 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 2517 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 2953 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1992 | 116 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5306 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 4032 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2007 | 6282 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4913 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1992 | 256 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13643 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 594 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 5098 | 0.000 |
Why?
|
| Macrophages | 1 | 2002 | 5783 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 568 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1987 | 972 | 0.000 |
Why?
|
| Infant | 1 | 2007 | 36461 | 0.000 |
Why?
|
| Smoking | 1 | 2002 | 9077 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 2551 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2002 | 13050 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13485 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6287 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1992 | 4712 | 0.000 |
Why?
|
| Lung | 1 | 1992 | 10067 | 0.000 |
Why?
|